Van Royen EA - Search Results

1

[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.

Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA. Booij J, et al. Among authors: van royen ea. Synapse. 1997 Nov;27(3):183-90. doi: 10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3.0.CO;2-9. Synapse. 1997. PMID: 9329154

2

In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.

Rijks LJ, Booij J, Doornbos T, Boer GJ, Ronken E, de Bruin K, Vermeulen RJ, Janssen AG, Van Royen EA. Rijks LJ, et al. Among authors: van royen ea. Synapse. 1996 Jul;23(3):201-7. doi: 10.1002/(SICI)1098-2396(199607)23:3<201::AID-SYN9>3.0.CO;2-C. Synapse. 1996. PMID: 8807748

3

Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.

Vermeulen RJ, Wolters EC, Tissingh G, Booij J, Janssen AG, Habraken J, Sokole-Busemann E, Stoof JC, Van Royen EA. Vermeulen RJ, et al. Among authors: van royen ea. Nucl Med Biol. 1995 Nov;22(8):985-91. doi: 10.1016/0969-8051(95)02020-9. Nucl Med Biol. 1995. PMID: 8998476 Clinical Trial.

4

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA. Booij J, et al. Among authors: van royen ea. Eur J Nucl Med. 1997 Jan;24(1):68-71. doi: 10.1007/BF01728311. Eur J Nucl Med. 1997. PMID: 9044880

5

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA. Booij J, et al. Among authors: van royen ea. J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048712 Free PMC article. Clinical Trial.

6

Development of radioligands for the imaging of cardiac beta-adrenoceptors using SPECT. Part II: Pharmacological characterization in vitro and in vivo of new 123I-labeled beta-adrenoceptor antagonists.

Dubois EA, Somsen GA, van den Bos JC, Janssen AG, Batink HD, Boer GJ, van Royen EA, Pfaffendorf M, van Zwieten PA. Dubois EA, et al. Among authors: van den bos jc, van royen ea, van zwieten pa. Nucl Med Biol. 1997 Jan;24(1):9-13. doi: 10.1016/s0969-8051(96)00120-5. Nucl Med Biol. 1997. PMID: 9080469

7

The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer.

Rijks LJ, Boer GJ, Endert E, de Bruin K, Janssen AG, van Royen EA. Rijks LJ, et al. Among authors: van royen ea. Nucl Med Biol. 1997 Jan;24(1):65-75. doi: 10.1016/s0969-8051(96)00183-7. Nucl Med Biol. 1997. PMID: 9080477

8

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.

Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Booij J, et al. Among authors: van royen ea. Eur J Nucl Med. 1998 Jan;25(1):24-30. Eur J Nucl Med. 1998. PMID: 9396871 Clinical Trial.

9

Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).

Rijks LJ, van den Bos JC, van Doremalen PA, Boer GJ, de Bruin K, Doornbos T, Vekemans JA, Posthumus MA, Janssen AG, van Royen EA. Rijks LJ, et al. Among authors: van den bos jc, van doremalen pa, van royen ea. Nucl Med Biol. 1998 May;25(4):411-21. doi: 10.1016/s0969-8051(97)00223-0. Nucl Med Biol. 1998. PMID: 9639304

10

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC. Tissingh G, et al. Among authors: van royen ea. J Nucl Med. 1998 Jul;39(7):1143-8. J Nucl Med. 1998. PMID: 9669384 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page